Search Results - christopher+cogle

2 Results Sort By:
Anti-Viral Agent for Treating Relapsed or Refractory AML and MDS through Immune System Activation
Harnesses the Body’s Own Immune Response Against Malignant Cells to Cause Disease Regression See how the abacavir binds to HLA-B*57:01 here. This antiviral agent stimulates patients’ own immune system against malignant cells to cause disease regression. Cancer remains one of the most costly and challenging diseases to treat, particularly...
Published: 6/22/2026   |   Updated: 6/22/2026   |   Inventor(s): David Ostrov, Christopher Cogle
Keywords(s):  
Category(s): Technology Classifications > Human Health Care > Therapeutics
Compounds for Treating Cancer and Cancer Stem Cells
High-Throughput Assay and Compounds Selective for Targeting Refractory Cancers and Cancer Stem CellsCurrently, there are limited therapies available to treat people with refractory cancers like acute myeloid leukemia (AML), non-small cell lung cancer (NSCLC) and triple negative breast cancer (TNBC). To solve this problem, University of Florida scientists...
Published: 1/20/2026   |   Updated: 5/16/2019   |   Inventor(s): Peter Sayeski, Amy Meacham, Christopher Cogle
Keywords(s): AML, Blood Vessels, Cancer, In vitro, leukemia, LLS, TPIMS
Category(s): Technology Classifications > Human Health Care > Therapeutics